Bio: Michael L. Moeller, PhD, has worked in the CGT space for 25 years, including roles as the Chief Scientific Officer of a Biotech startup, as the Scientific Director of the CGT unit of a CRO, and multiple roles in business development at life science companies. He has advanced one of his cellular therapies into 2 Phase I Clinical Trials and is currently focused on becoming a supportive presence for the larger CGT field.